Know Cancer

forgot password

Low Level Laser Therapy for Hair Preservation With Chemotherapy for Breast Cancer

18 Years
Not Enrolling
Breast Cancer

Thank you

Trial Information

Low Level Laser Therapy for Hair Preservation With Chemotherapy for Breast Cancer

Chemotherapy is a common treatment given to patients with breast cancer. Many chemotherapy
drugs cause rapid hair loss. While hair loss is temporary, this side effect is a significant
concern for patients. Low level laser therapy has been shown to help make hair grow. It is
hoped that it may stop hair loss from occurring.

Participants will be receiving 20 to 30 minute laser sessions to their scalp twice a week
beginning two weeks before treatment begins until one week past the last chemotherapy
session. . Photographs will be taken during each study participant's initial visit, during
treatment visits, and one month following the final chemotherapy treatment.

Inclusion Criteria:

- Participants must have breast cancer and must be starting chemotherapy with
Adriamycin or a taxane-based therapy.

- Participants must be 18 years old or older

- Participants must be female

- Participant must agree to comply with therapeutic and follow-up schedule.

- Patient must signed informed consent form.

Exclusion Criteria:

- Participants cannot have sensitivity to the laser light.

- Participants cannot have used any topical or oral products to grow hair within 3
months of enrollment to this study.

- Participants cannot be pregnant, lactating or planning on pregnancy during
therapeutic schedule.

Type of Study:


Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Outcome Measure:

10 Point Scale to evaluate hair loss

Outcome Description:

The primary objective is to evaluate the ability of Low-Level Laser Therapy (LLLT) to prevent chemotherapy induced alopecia in women receiving adjuvant chemotherapy for breast cancer.

Outcome Time Frame:

Photographs evaluated weekly during treatment, one month post chemotherapy

Safety Issue:


Principal Investigator

Jamie Van Roenn, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Northwestern University


United States: Institutional Review Board

Study ID:

NU 09CC2



Start Date:

Completion Date:

Related Keywords:

  • Breast Cancer
  • Breast Cancer
  • Breast Neoplasms